<SEC-DOCUMENT>0001599298-20-000001-index.html : 20200102
<SEC-HEADER>0001599298-20-000001.hdr.sgml : 20200102
<ACCEPTANCE-DATETIME>20200102163914
ACCESSION NUMBER:		0001599298-20-000001
CONFORMED SUBMISSION TYPE:	D
PUBLIC DOCUMENT COUNT:		1
ITEM INFORMATION:		<ITEMS>06b
FILED AS OF DATE:		20200102
DATE AS OF CHANGE:		20200102
EFFECTIVENESS DATE:		20200102

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Summit Therapeutics plc
		CENTRAL INDEX KEY:			0001599298
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			X0
		FISCAL YEAR END:			0131

	FILING VALUES:
		FORM TYPE:		D
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	021-357007
		FILM NUMBER:		20501986

	BUSINESS ADDRESS:	
		STREET 1:		136A EASTERN AVENUE
		STREET 2:		MILTON PARK
		CITY:			ABINGDON
		STATE:			X0
		ZIP:			OX14 4SB
		BUSINESS PHONE:		44-123-544-3939

	MAIL ADDRESS:	
		STREET 1:		136A EASTERN AVENUE
		STREET 2:		MILTON PARK
		CITY:			ABINGDON
		STATE:			X0
		ZIP:			OX14 4SB

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Summit Corp plc
		DATE OF NAME CHANGE:	20140205
</SEC-HEADER>
<DOCUMENT>
<TYPE>D
<SEQUENCE>1
<FILENAME>primary_doc.xml
<TEXT>
Document 1 - file: primary_doc.html

Document 1 - RAW XML: primary_doc.xml

</DOCUMENT>
</SEC-DOCUMENT>